Climate change

Compared to 2022, there was a 27.16% reduction in scope 1 and scope 2 emissions. This reduction was mainly due to the actions taken in transport between the Distribution Centers and the Pharmacies (page 96), and the increased consumption of energy from renewable sources.

In 2024, we will implement a pilot project with suppliers responsible for emissions from purchased goods and services to engage them in decarbonization strategies.

We reached 72% of operations supplied with renewable energy.

The Company’s efforts to reduce GHG emissions and optimize energy use in a sustainable manner.

At RD Saúde, risk management is guided by the Risk Management Policy, which references national and international practices such as ISO 31000, COSO ERM, and the guidelines of the Brazilian Institute of Corporate Governance (IBGC) and the Institute of Internal Auditors of Brazil (IIA Brasil). The policy sets out guidelines and responsibilities based on the […]

Energy consumption within the organization¹ (GJ) 2023² 2024² 2025 Non-renewable resources Fuels LPG 166.88 179.79 196.39 Fuels Kerosene 10,419.16 11,272.51 9,183.31 Fuels CNG³ 0.00 0.00 2,309.53 Fuels Diesel 77,193.69 130,434.31 135,042.27 Electricity Electricity(utility company) 368,740.19 0.00 0.00 Total 456,519.92 141,886.61 146,731.50 Renewable energy sources Fuels Biodiesel⁴ 8,575.57 17,702.24 19,421.60 Electricity Electricity (open market and distributed […]

RD Saúde does not track energy consumption outside the organization.

Energy intensity 2023¹ 2024¹ 2025 Total energy consumption (GJ)² 846,162.77 1,028,160.93 1,211,660.61 Floor area (m²)³ 1,053,600.99 1,184,976.42 1,317,710.74 Energy intensity (GJ/m²) 0.80 0.87 0.92 ¹The historical data has been updated to reflect improvements in the consolidation methodology and presentation format. GRI 2-4²Includes the organization’s total energy consumption, taking into account both renewable and non-renewable fuels […]

In the 2025 cycle, we did not record a reduction in energy consumption.

Check out the quantitative data on Scope 1 emissions from RD Saúde. Information on Scopes 2 and 3 emissions can be verified in disclosure 305-2 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]

Check out the quantitative data on Scope 2 emissions from RD Saúde. Information on Scopes 1 and 3 emissions can be verified in disclosures 305-1 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]

Check out the quantitative data on Scope 3 emissions from RD Saúde. Information about Scopes 1 and 2 emissions can be verified in disclosures 305-1 and 305-2. Also check out qualitative information about our climate journey in the TCFD tab of this panel. Emissão biogênica por escopo (tCO2e)1 2021 2022 2023 Escopo 1 24.596,19 29.051,29 […]

The intensity of emissions was 3.86 tCO2/t of products in 2023, which accounts for a 19% reduction compared to 2022. Notas: 1. Includes the categories: waste generated in operations, business travel, transport and distribution (downstream), use of goods and services sold, end-of-life treatment of products sold and investments. 2. Drugs, over-the-counter (OTC) drugs, and perfumery […]

Since 2021, we have been making progress in the use of electric trucks for B2B deliveries, i.e. the route from Distribution Centers to pharmacies. In addition, part of the fleet has switched to S10 diesel, a less carbon-intensive fuel. We continue working to strengthen the partnerships with last mile delivery companies to increase the use […]

1) The total energy consumption (fuel and electricity) was 1,211,660.61 GJ.2) The percentage of electricity from the grid was 33.81%.3) The percentage of renewable energy was 87.89%.

RD Saúde’s Board of Directors monitors climate-related risks and opportunities with the support of its advisory committee structure, which informs strategic decision-making. The Audit Committee assesses and monitors risk exposures and risk management, including climate-related risks, ensuring that appropriate control mechanisms and action plans are in place. In addition, the Sustainability Committee monitors and discusses […]

The Board of Directors is responsible for overseeing the operational mechanisms related to risk management, ensuring that financial policies are consistent with strategic guidelines and the business’ risk profile, as well as for approving the guidelines for the company’s corporate governance framework for risk management—including methodology, policies, processes, and systems—when duly recommended by the Audit […]

RD Saúde conducts a structured assessment of climate-related risks and opportunities, taking into account the likelihood of each event occurring and its potential impact on the business. Physical risks: The following threats were identified: river flooding (distribution centers and pharmacies — long term), storms (distribution centers and pharmacies — long term), heat waves (distribution centers […]

Climate risks and opportunities are linked to the company’s long-term vision, influencing the development of its 2030 sustainability strategy, which guides its operations. They also have an impact on financial planning, since climate adaptation and mitigation initiatives—such as the purchase of electric trucks, the installation of flood barriers, and the purchase of insurance against extreme […]

RD Saúde incorporates climate risks and opportunities into its strategy based on internationally recognized scientific scenarios, with a focus on the 2030 and 2050 time horizons. For physical risks, the IPCC’s SSP1-2.6 and SSP3-7.0 scenarios are used; for transition risks, the IEA’s SSP1-1.9, SSP1-2.6, and SSP2-4.5 scenarios are used—covering everything from aggressive mitigation approaches to […]

RD Saúde conducts an annual assessment to identify and analyze climate risks. The most recent one covers all assets in operation in 2025: RD Saúde Campus, 15 distribution centers, 1 hub, and 3,547 pharmacies. The process is multidisciplinary, involving the areas of Sustainability, Risk Management, Procurement, Pharmacy Operations, Engineering, and Expansion. The severity of the […]

Climate risk management at RD Saúde follows the same process as corporate risk management. Each risk is assigned to a responsible department, which conducts the necessary controls and implements improvement measures. Monitoring is performed by the Risk Management Committee, an advisory body to the Executive Board, with regular meetings organized according to the nature of […]

Since 2022, climate risks have been formally incorporated into RD Saúde’s corporate risk matrix, following the same methodology, assessment criteria, and governance process applied to the company’s other risks. The Risk Management Department maintains ongoing coordination with the Sustainability Department and the business units directly involved to monitor and address these risks in an integrated […]

To assess climate risks and opportunities, RD Saúde uses metrics structured around two dimensions: impact and probability. The impact is assessed based on four criteria—financial (percentage impact on adjusted EBITDA or net income), image and reputation (negative repercussions and reputational impact), operational (unavailability of distribution centers and systems, and disruption to e-commerce), and regulatory (penalties, […]

The data are available on pages 58 and 68 of the 2025 Annual and Sustainability Report.

RD Saúde manages the risks and opportunities associated with climate change through the goals that make up its 2030 sustainability strategy: Progress on these commitments is reported quarterly to the Sustainability Committee and made publicly available at painelesg.rdsaude.com.br. Detailed performance data is also available on page 58 of this report. In addition to its long-term […]